Business ❯ Finance ❯ Market Analysis

Investment Opportunities

AI Stocks Analyst Ratings Housing Stocks Management Buyout Trends Inox Wind Fintech Companies Penny Stocks UK Mortgage Market Long-term Growth Mining Sector IPO Strategies Bitcoin Holdings Comparative Analysis Risk Management Berkshire Hathaway Portfolio Tata Capital IPO Details Tata Capital IPO Telecommunications Sector Underappreciated Stocks Undervalued Stocks Energy Transfer Medical Cannabis Tech Companies Future Projections REIT Market Emerging Technologies Long-term Investments High-Growth Stocks Growth Stocks Buy the Dip

Tilray Rises on Record Q2 Beat as CEO Details U.S. Medical Push

The upside sharpened focus on a new U.S. medical unit built for FDA trials, positioning the company for possible rescheduling.

Rivian Extends Slide to Six-Day Losing Streak After CEO Share Sale Disclosure

Megadeals Drive 2025 M&A to $4.5 Trillion as U.S. Targets Lead

Nebius Closes $4.16 Billion Financing After Microsoft AI Capacity Deal, Speeds Vineland Buildout